A once-in-a-decade opportunity to buy these ASX 200 growth shares before they rocket?

Is now the time to seize on market weakness to buy these highly rated stocks?

| More on:
A group of people in suits watch as a man puts his hand up to take the opportunity.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

I think it is fair to say that the past few weeks have been difficult for investors. Particularly those that invest in ASX 200 growth shares.

The dramatic selloff has seen many shares retreating sharply from their recent highs.

While it is disappointing to see your portfolio shed value, every cloud has a silver lining.

The silver lining here is that it could have created a once-in-a-decade opportunity that investors have been waiting for – a chance to buy quality ASX 200 growth shares at a discount before they rebound and potentially rocket to new highs.

But which growth shares could be worth buying right now? Let's take a look at three that analysts are tipping as buys. They are as follows:

Lovisa Holdings Ltd (ASX: LOV)

The first ASX 200 growth share to consider buying after the selloff is Lovisa. This fashion jewellery retailer's shares have pulled back by over 7% from recent highs.

Analysts at Morgans will see this as a buying opportunity. Following a similar pullback at the end of last year, the broker commented: "Lovisa has proven it can successfully build out its unique brand in many diverse territories around the world on its journey to becoming a truly global brand. It's at times like these that investors should be getting set to reap the rewards of this strategy over the longer term."

Morgans has an add rating and $37.00 price target on its shares.

Pro Medicus Limited (ASX: PME)

Another ASX 200 growth share that was dragged lower during the market selloff is Pro Medicus. It is a leading provider of radiology information systems (RIS), Picture Archiving and Communication Systems (PACS), and advanced visualisation solutions across the globe.

Analysts at Goldman Sachs are likely to see this pullback as a great opportunity for investors to buy this high quality company. Particularly given how the broker sees "PME as the clear incumbent technology leader in a growing market with a strong financial profile and significant AI upside."

It has a buy rating and $148.00 price target on its shares.

Xero Ltd (ASX: XRO)

A final stock that could be a top option for investors is Xero. This leading cloud-based accounting software provider is another ASX 200 growth share that has been caught up in the recent selloff.

However, despite the near-term volatility, Xero's long-term growth prospects remain very bright thanks to the structural shift to the cloud. In fact, Goldman Sachs estimates that it has a total addressable market of 100 million small to medium sized businesses. This compares to its current subscriber base of 4.2 million.

Goldman believes this gives it a multi-decade growth runway. It is no surprise then that it is tipping its shares as a buy with a $180.00 price target.

Motley Fool contributor James Mickleboro has positions in Lovisa, Pro Medicus, and Xero. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Lovisa, Pro Medicus, and Xero. The Motley Fool Australia has positions in and has recommended Xero. The Motley Fool Australia has recommended Lovisa and Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

man looking at mobile phone and cheering representing surging asx share price
Growth Shares

3 stellar ASX growth shares to supercharge your portfolio returns

Big returns could be on offer from these shares according to analysts.

Read more »

A smiling travel agent sitting at her desk working for Corporate Travel Management
Growth Shares

Investing for growth? Here are 6 ASX stocks Macquarie tips to outperform

Top broker Macquarie reveals its 12-month share price targets for several growth stocks.

Read more »

A woman makes the task of vacuuming fun, leaping while she pretends it is an air guitar.
Growth Shares

Where I'd invest $5,000 in ASX growth shares right now

These stocks could deliver significant profit growth in the next few years.

Read more »

A young man punches the air in delight as he reacts to great news on his mobile phone.
Growth Shares

Buy and hold these ASX growth shares for a decade

Looking for long term options? Analysts rate these stocks as buys.

Read more »

A woman smiles as she sits on the bus using her phone and listening to music through headphones.
Growth Shares

2 compelling ASX shares I'd buy in September

I’m excited by the long-term potential of these under-the-radar businesses.

Read more »

a mature but cool older woman holds a watering can and tends to a healthy green plant growing up the wall in her house.
Growth Shares

Overinvested in CSL shares? Here are two alternative ASX growth stocks

These stocks offer a lot of growth potential.

Read more »

Two smiling work colleagues discuss an investment or business plan at their office.
Growth Shares

Analysts are tipping these ASX growth shares as top buys

Why are they bullish on these names? Let's find out.

Read more »

A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
Growth Shares

These excellent ASX growth shares could rise 15% to 40%

Analysts are expecting outsized returns from these stocks.

Read more »